IMPACCT: mHealth in Clinical Trials is organized by Hanson Wade and will be held from Apr 15 - 17, 2019 at Amba Hotel Marble Arch, London, England, United Kingdom.
The 2nd annual IMPACCT: mHealth in Clinical Trials London 2019 provides a dedicated forum for industry experts to share data, best practice and innovation on how to accelerate the successful implementation of game-changing digital strategies in clinical studies and harness the power of mobile technologies to transform the clinical research paradigm.
Technological capabilities, regulatory advances and a quest for clinical innovation are now, more than ever, coming together to transform the way clinical studies are conducted, the way we recruit and engage patients and the way we collect and utilise clinical data.
At a point of increasing maturity but also growing innovation, these are exciting times for all stakeholders actively involved in bringing the use of digital health technologies in clinical research to the next level.
We’ve been seeing exciting developments in this space, with more and more use-cases of actual implementation of these capabilities in clinical programs to support and drive patient-centricity, exciting initiatives and new discussions emerging.
• How is the clinical trial paradigm being disrupted with innovative methodologies such as decentralised trials?
• What are the next steps in remote patient monitoring or in digital endpoints?
• How is the understanding of patient data ownership changing healthcare?
Workshop A: 09.00 - 12.00
Advancing the Use of Blockchain Technology in Clinical Trials
The application of blockchain technology in clinical trials is sparking a lot of interest in the pharmaceutical industry. Blockchain has the potential to be a game changer in the way clinical studies are conducted – opportunities go from streamlining patient recruitment to ensuring patient data security and enhancing data transparency. In this workshop, Manuela and Michaela transpose their expertise in emerging technologies being used in the pharmaceutical sector and address the impact of blockchain in clinical trials, the opportunities and the challenges ahead.
Join this brainstorming discussion to learn more about the potential of blockchain technology within the clinical trial setting.
Key areas to be discussed include:
• Systematic analysis of the current market and future
• trendsDevelopment of problem statement(s)Potential
• solutionsApplication of design-thinking methodologies
Workshop B: 13.00 - 16.00
Enhancing Patient Engagement & Succeeding Where Others Have Failed
Pharma is heavily dependent on finding the right patients for clinical trials to accelerate recruiting and ensure that patients remain compliant throughout the trial – to the end. In oncology, this is
especially critical to proving efficacy and ensuring that knowledge is maximized for current treatments and especially future ones. The industry has seen trials delayed and even fail repeatedly due to identifying the wrong patients, as well as not maintaining their interest all the way to completion. This costs pharma companies a lot of money.
This workshop aims to create a thought-provoking discussion led by David Goren, a pharma veteran and expert in the digital innovation space.
Join this interactive, comprehensive and collaborative session that will allow you to employ innovative digital approaches in clinical programs to improve clinical and financial results.
Key topics to be discussed include:
• Main hurdles faced in attracting the right patients and keeping them engaged in your clinical programs with digital tools and methodologies
• Internal challenges – innovation as a driver for success
• External challenges – the role and positioning of external stakeholders including patients, investigators and institutions
• Patient Engagement from start to finish
• Start from patient needsFollow the patients throughout the trial experience
• What motivates the patient and what are the barriers?
• What can be leveraged in the environment (e.g., caregivers)?
Alexander Klein, Roche, Anne-Marie Li-Kwai-Cheung, Roche, Bert Hartog, Janssen Pharmaceuticals, Bryan McDowell, Novartis, Caroline Feys, Janssen Pharmaceuticals, Corey Fowler, Otsuka Pharmaceutical Co., Independent Consultant, AstraZeneca, Florent Schäfee. Danone, Isabela Niculae, Biogen, Jyothis George, Boehringer Ingelheim, Lisa Shipley, Merck & Co., Manuela Schöner, Boehringer Ingelheim, Michaela Kazmaier, Dimension Data, Sam Hariry, Novartis Institutes for Biomedical Research (NIBR, Sheli Gupta, Hu-manity.co, Theodoros Arvanitis, University of Warwick, Tom Denwoodd, NHS Digital
Additional details will be posted as soon as they are available.
|Contact No. :||+44 (0)20 3141 8700
+44 (0)20 3141 8700
|Registration Type||End Date||Price|
|Conference 2 Workshops Standard Fee||14 Apr,2019||GBP 3197.00|
|Conference 1 Workshops Standard Fee||14 Apr,2019||GBP 2698.00|
|Conference Only Standard Fee||14 Apr,2019||GBP 2199.00|
|Workshop Only - Each Fee||14 Apr,2019||GBP 599.00|